Dare Bioscience, Inc (DARE) Stock Price

0.8014 ▼ -0.0317 (-3.81%)
Open: 0.8014 Vol: 0 Day's range: 0.8014 - 0.8014 Oct 07, 13:10 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DARE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.83▼ 0.83▼ 0.83▼ 0.83▼ 0.78▲
MA10 0.84▼ 0.84▼ 0.84▼ 0.81▼ 0.85▼
MA20 0.84▼ 0.84▼ 0.84▼ 0.79▲ 1.37▼
MA50 0.85▼ 0.84▼ 0.82▼ 0.91▼ 1.71▼
MA100 0.82▼ 0.81▼ 0.79▲ 1.45▼ 2.24▼
MA200 0.79▲ 0.78▲ 0.82▼ 1.69▼ 4.70▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.004▼ -0.004▼ -0.006▼ 0.020▲ -0.050▼
RSI 31.006▼ 36.496▼ 39.254▼ 45.323▼ 35.905▼
STOCH 19.484▼ 27.339     25.329     76.202     8.133▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -43.960     -92.317▼
CCI -253.151▼ -290.366▼ -261.115▼ -30.149     -49.797    
Latest Filters Detected On DARE
MA $DARE Price Crossed Below MA(13) Set Alert
MA $DARE Price Crossed Below MA(7) Set Alert
▼ GAP $DARE Open Gap Down %3 Set Alert
▼ GAP $DARE Open Gap Down %2 Set Alert
CDL $DARE Doji Candlestick Pattern Detected Set Alert
Dare Bioscience, Inc News
Daré Bioscience, Inc.: Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Monday, September 28, 2026 09:09 AM
New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV infection DARE-HPV Phase 2 study underway with topline ...
Dare Bioscience stock rises after receiving HPV treatment patent
Monday, September 28, 2026 07:32 AM
Dare Bioscience Inc (NASDAQ:DARE) shares rose 2.8% on Monday following the announcement that the company received a new U.S. patent for its HPV treatment program.
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Monday, September 28, 2026 01:19 AM
New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV ...
DARE historical stock data
date open high low close volume
07/10/26 0.8014 0.8014 0.8014 0.8014 62,252
06/10/26 0.83 0.88 0.83 0.8331 88,343
05/10/26 0.833 0.8689 0.8308 0.8431 157,134
02/10/26 0.869 0.8775 0.8224 0.8428 146,561
01/10/26 0.86 0.8701 0.83 0.851 135,127
30/09/26 0.80 0.88 0.7683 0.8533 277,625
29/09/26 0.7869 0.8671 0.7356 0.815 639,715
28/09/26 0.79 0.816 0.7012 0.75 696,829
25/09/26 0.77 0.7895 0.7458 0.7755 116,434
24/09/26 0.8023 0.8456 0.7117 0.7405 469,425
Quote Details
52wk Low:0.69
52wk High:3.78
Vol:0
Avg Vol(3m):8.1M
1Y Chng:-61.66%
1M Chng:+6.77%
Add to Watch List
More Information
Index US Composite
Market Cap. 16.58M